|
| Press Releases |
|
 |
|
| Wednesday, July 19, 2017 |
|
|
联康生物科技获香江大健康基金注资1.2亿港元 成为集团策略性股东 |
| 联康生物科技集团有限公司（「联康生物科技」、「联康」或「集团」；股份代号：690）今天宣布，集团获国内知名大型综合企业香江集团牵头的香江大健康基金注资1.2亿港元成为集团策略性股东 more info >> |
|
|
聯康生物科技獲香江大健康基金注資1.2億港元 成為集團策略性股東 |
| 聯康生物科技集團有限公司（「聯康生物科技」、「聯康」或「集團」；股份代號：690）今天宣佈，集團獲國內知名大型綜合企業香江集團牽頭的香江大健康基金注資1.2億港元成為集團策略性股東 more info >> |
|
|
HeungKong Great Health Fund I Injects HK$120 Million into Uni-Bio Science and Becomes its Strategic Shareholder |
| Uni-Bio Science Group Limited ("Uni-Bio Science", "Uni-Bio" or the "Group"; HKEx code: 690) today announced that HeungKong Great Health Fund I, led by the famed Mainland China-based corporation HeungKong Group, has invested HK$120 million in the Group and become its strategic shareholder. more info >> |
|
| Monday, February 27, 2017 |
|
|
联康生物科技旗下药物获列入国家医保药品目录 |
| 联康生物科技集团有限公司（「联康生物科技」或「集团」；股份代号：690）今天宣布，其产品米格列奈今天获列入由中国人力资源和社会保障部发布的国家医保药品目录。 more info >> |
|
|
聯康生物科技旗下藥物獲列入國家醫保藥品目錄 |
| 聯康生物科技集團有限公司（「聯康生物科技」或「集團」；股份代號：690）今天宣佈，其產品米格列奈今天獲列入由中國人力資源和社會保障部發佈的國家醫保藥品目錄。 more info >> |
|
|
Uni-Bio Science's Drugs Officially Reimbursed under the National Reimbursement Drug List |
| Uni-Bio Science Group Limited ("Uni-Bio Science" or the "Group;" HKEx code: 690) has announced that its product Mitiglinide is now to be officially reimbursed under the National Reimbursement Drug List ("NRDL") published by Ministry of Human Resources and Social Security today. more info >> |
|
| Friday, August 26, 2016 |
|
|
联康生物科技集团公布二零一六年中期业绩 |
联康生物科技集团有限公司（「联康生物科技」或「集团」；股份代号：690）宣布截至二零一六年六月三十日止六个月之中期业绩。集团新设立的市场准入部门有效管理招标，加上成功加强其商业平台以及成功进入新的增长省份，带动集团录得强劲的财务及营运业绩。
more info >> |
|
|
聯康生物科技集團公佈二零一六年中期業績 |
聯康生物科技集團有限公司（「聯康生物科技」或「集團」；股份代號：690）宣佈截至二零一六年六月三十日止六個月之中期業績。集團新設立的市場准入部門有效管理招標，加上成功加強其商業平台以及成功進入新的增長省份，帶動集團錄得強勁的財務及營運業績。
more info >> |
|
|
Uni-Bio Science Group Announces 2016 Interim Results |
| Uni-Bio Science Group Limited ("Uni-Bio Science" or the "Group"; HKEx code: 690) has announced its interim results for the six months ended 30 June 2016. more info >> |
|
| Monday, June 27, 2016 |
|
|
联康生物科技与华润紫竹就金因舒®达成战略联盟 |
| 联康生物科技集团有限公司（「联康生物科技」或「集团」；股份代号：690）今天宣布，集团与华润医药集团旗下专注于在国内开发、制造及销售眼科及生殖健康用药的全资附属公司─华润紫竹药业有限公司（「华润紫竹」）签订战略联盟协议。 more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
富士通、実用的な量子計算の実現に向けて、1万量子ビット超の超伝導量子コンピュータの研究開発を開始
Aug 1, 2025 10:30: JST
|
|
|
Honda Begins Joint Demonstration of Stationary Fuel Cell Power Station Designed to Utilize By-product Hydrogen and Repurposed Automotive Fuel Cells
Aug 1, 2025 11:20 JST
|
|
|
Isuzu's first battery-electric pickup "D-MAX EV" adopts eAxle
Aug 1, 2025 11:00 JST
|
|
|
A Bold New Chapter Begins at CEO SUITE
Aug 1, 2025 10:00 HKT/SGT
|
|
|
CEO SUITE開啟嶄新篇章
Aug 1, 2025 10:00 HKT/SGT
|
|
|
Shoucheng's Capital Leap: Zhao Tianyang Drives 2025 Upswing
Aug 1, 2025 09:40 HKT/SGT
|
|
|
從黑馬投資人到產業引領者 趙天暘領銜首程控股迎來「投資豐收年」
Aug 1, 2025 09:40 HKT/SGT
|
|
|
从黑马投资人到资本引领者 赵天旸领衔首程控股开启“丰收年”
Aug 1, 2025 09:30 HKT/SGT
|
|
|
Fujitsu starts official development of plus-10,000 qubit superconducting quantum computer targeting completion in 2030
Aug 1, 2025 10:20 JST
|
|
|
Scipio Capital Advisors、資本調達により認定投資家にオルタナティブ資産の利回りを提供
Aug 1, 2025 09:00: JST
|
|
|
Shoucheng Buys Back 20M Shares in 2 Days, Signals Strong Bet
Aug 1, 2025 08:30 HKT/SGT
|
|
|
Scipio Capital Advisors 資本募集行動讓合格投資人觸及另類資產收益
Aug 1, 2025 08:00 HKT/SGT
|
|
|
GTJAI Successfully Issued the First Publicly Offered Digital Bond of a Chinese Securities Firm
Aug 1, 2025 00:00 HKT/SGT
|
|
|
國泰君安國際成功發行中資券商首筆公募數碼原生債券
Jul 31, 2025 23:50 HKT/SGT
|
|
|
Scipio Capital Advisors Capital Raise puts Alternative Asset Yield Within Reach of Accredited Investors
Jul 31, 2025 20:25: JST
|
|
|
|
|
More News >> |
|
|
|
|
|
